Phase I Study to Assess the Safety of APD-791 When Co-administered With Aspirin
Phase of Trial: Phase I
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Temanogrel (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms PR1C; TG1C
- Sponsors Ildong Pharmaceutical
- 12 May 2014 According to the Arena Pharmaceuticals media release, Ildong Pharmaceutical has initiated dosing in this trial.
- 12 May 2014 Status changed from not yet recruiting to recruiting according to the Arena Pharmaceuticals media release.
- 23 Jan 2014 New source identified and integrated (ClinicalTrials.gov, NCT02034292)